BenevolentAI

BenevolentAI combines biomedical knowledge graphs and proprietary ontologies with machine learning to identify drug targets and predict how candidate molecules will behave in the body, focusing on diseases with limited treatment options. Researchers use it to mine scientific literature, clinical data, and genomic databases for connections that humans might overlook. Its Qor product serves as an always-on strategic function for biopharma decision makers and life science consultancies.